Skip to content

Antiverse vs Zymeworks Inc.

Antiverse logo

Antiverse

Designing functional antibodies for the most challenging targets

34 employees · est. 2017 · Cardiff, United Kingdom

VS
Zymeworks Inc. logo

Zymeworks Inc.

Developing novel medicines for patients with difficult-to-treat cancers and other serious diseases

264 employees · est. 2003 · Canada

Zymeworks Inc. is the older company (2017 vs 2003); Zymeworks Inc. is the larger of the two.

Side-by-Side Comparison

Antiverse Zymeworks Inc.
Founded
2017 2003 older
Headquarters
Cardiff, United Kingdom Canada
Employees
34 264 larger
Industry
AI, Biotechnology, Health Care Biotechnology, Health and Wellness
Funding Stage
Series A IPO
Total Funding
$21.82M $867.80M
Funding Rounds
10 17
Services
Antibody design for challenging targets, Pharmaceutical partnerships, In silico drug discovery, Machine learning model development Development of novel medicines, Antibody drug creation, Pipeline management, Partnership and collaboration in drug development
Target Customers
Pharmaceutical companies, Biotech firms, Healthcare researchers Patients with difficult-to-treat diseases, Healthcare providers, Pharmaceutical companies, Biotechnology partners
Taxonomy
Antibody DesignChallenging Drug TargetsGPCR TherapeuticsIon Channel TherapeuticsTechBioCell Line Engineering +7 Antibody TherapeuticsCancer TreatmentAutoimmune DiseasesInflammatory DiseasesProtein EngineeringAntibody-drug Conjugates +8
Website
antiverse.io zymeworks.com
Antiverse logo

About Antiverse

Antiverse, founded in 2017, is a promising Welsh techbio company that specializes in the design of antibodies targeting difficult drug targets such as GPCRs and ion channels. The company’s mission is encapsulated in its slogan: "Designing functional antibodies for the most challenging targets." Wit...

Zymeworks Inc. logo

About Zymeworks Inc.

Zymeworks Inc. is a seasoned player in the biotechnology and health and wellness industries, founded in 2003 and headquartered in Canada. The company is committed to innovating medicine development for hard-to-treat cancers and serious diseases, as reflected in their slogan: "Developing novel medici...

Also comparing in this category

Comparing more than these two?

Get Antiverse, Zymeworks Inc. and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.

How does Antiverse compare?

A PDF of Antiverse and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Rival Readout

Comparing competitors? We do this properly.

10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.

Frequently Asked Questions

Antiverse was founded in 2017, based in Cardiff, United Kingdom, with 34 employees. Antiverse, founded in 2017, is a promising Welsh techbio company that specializes in the design of antibodies targeting difficult drug targets such as GPCRs and ion channels. The company’s mission is. Zymeworks Inc. was founded in 2003, based in Canada, with 264 employees. Zymeworks Inc. is a seasoned player in the biotechnology and health and wellness industries, founded in 2003 and headquartered in Canada. The company is committed to innovating medicine development fo.
Antiverse has raised $21.82M and Zymeworks Inc. $867.80M. Latest stage: Antiverse Series A, Zymeworks Inc. IPO.
Both work in Biotechnology.

Compare Antiverse with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Antiverse on 15 Jun 2026, and Zymeworks Inc. on 18 Sep 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout